Patrick Lamy serves as Executive at Akero Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Patrick Lamy has executed 7 insider transactions totaling $118.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 9, 2025 involved selling 26,832 shares valued at $0.
Patrick Lamy currently holds 29,891 shares of Akero Therapeutics, Inc. (AKRO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Patrick Lamy has been a net seller of AKRO stock. They have purchased $0 and sold $118.6K worth of shares.
Patrick Lamy's most recent insider trade was on Dec 9, 2025, when they sold 26,832 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 1, 2025 | AKRO | $105.8K | Sale | 2,000 | $52.88 | Discretionary |
| Jun 30, 2025 | AKRO | $4.6K | Award | 193 | $23.87 | Discretionary |
| Jun 28, 2024 | AKRO | $4.4K | Award | 221 | $19.94 | Discretionary |
| Jun 11, 2024 | AKRO | $12.9K | Sale | 569 | $22.64 | Discretionary |
| Dec 8, 2023 | AKRO | $0 | Award | 18,570 | $N/A | Discretionary |